Skip to main content
SpringerLink
Log in
Book cover

Geriatric Medicine pp 939–948Cite as

Abnormalities of Posture and Movement

  • Chapter

  • 245 Accesses

Abstract

Alterations of posture and gait commonly accompany aging and can be indicators of the health and biologic age of an individual. They also affect quality of life by decreasing confidence, restricting mobility, and causing injuries. Posture and gait can be compromised by cardiovascular, arthritic, and orthopedic disorders, but are probably most commonly impaired by neurologic dysfunction. The neurologic disturbances that produce postural and gait abnormalities can be categorized under three headings: (1) afferent or sensory dysfunction, (2) efferent or motor dysfunction, and (3) central or integrative dysfunction.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nutt JG, Marsden CD, Thompson PD. Human walking and higher level gait disorders, particularly in the elderly. Neurology. 1993; 43: 268–279.

    Article  PubMed  CAS  Google Scholar 

  2. Elble RJ, Hughes L, Higgins C. The syndrome of senile gait./Neurol 1992; 239: 71–75.

    CAS  Google Scholar 

  3. Murphy J, Isaacs B. The post-fall syndrome: a study of 36 elderly patients. Gerontology. 1982; 82: 265–270.

    Article  Google Scholar 

  4. Fisher CM. Hydrocephalus as a cause of disturbances of gait in the elderly. Neurology. 1982; 32: 1358–1363.

    Article  PubMed  CAS  Google Scholar 

  5. Koller WC, Wilson RS, Glatt SL, et al. Senile gait: correlation with computed tomographic scans. Ann Neurol. 1983; 13: 343–344.

    Article  PubMed  CAS  Google Scholar 

  6. Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD. Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review. Neurology. 1992; 42 (l): 54–59.

    Article  PubMed  CAS  Google Scholar 

  7. Jenkyn LR, Reeves AG. Neurologic signs in uncomplicated aging (scenescence). Semin Neurol. 1981; 1: 21–30.

    Article  Google Scholar 

  8. Horak FB, Shupert CL, Mirka A. Components of postural dyscontrol in the elderly: a review. Neurobiol Aging. 1989; 10: 727–738.

    Article  PubMed  CAS  Google Scholar 

  9. Tinetti ME, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med. 1994; 331: 821–827.

    Article  PubMed  CAS  Google Scholar 

  10. Kurland LT. Epidemiology: incidence, geographic distribution and genetic considerations. In: Field WJ, ed. Pathogenesis and Treatment of Parkinsonism. Springfield, IL: Charles C. Thomas; 1958: 5–49.

    Google Scholar 

  11. Rajput AH. Frequency and cause of Parkinson’s disease. Can J Neurol Sci. 1992; 19: 103–107.

    PubMed  CAS  Google Scholar 

  12. Agid Y. Parkinson’s disease: pathophysiology. Lancet. 1991; 337: 1321–1327.

    Article  PubMed  CAS  Google Scholar 

  13. Alvord EC. The pathology of parkinsonism. In: Minekler J, ed. Pathology of the Nervous System. New York: McGraw- Hill; 1968: 1152–1161.

    Google Scholar 

  14. Gibb WRG. Dementia and Parkinson’s disease. Br J Psychiatry. 1989; 154: 596–614.

    Article  PubMed  CAS  Google Scholar 

  15. Boiler F, Mizutani T, Roessman U, et al. Parkinson disease dementia and Alzheimer disease: clinicopathological correlations. Ann Neurol. 1980; 7: 329–335.

    Article  Google Scholar 

  16. Hakim AM, Mathieson G. Dementia in Parkinson’s disease: a neuropathologic study. Neurology. 1979; 29: 1209–1214.

    Article  PubMed  CAS  Google Scholar 

  17. Mayeux R, Stern Y, Rosenstein R, et al. An estimate of the prevalence of dementia in idiopathic Parkinson’s disease. Arch Neurol. 1988; 45: 260–262.

    Article  PubMed  CAS  Google Scholar 

  18. Mayeux R, Chen J, Mirabello E, et al. An estimate of the incidence of dementia in idiopathic Parkinson’s disease. Neurology. 1990; 40: 1513–1517.

    Article  PubMed  CAS  Google Scholar 

  19. Brown RG, Marsden CD. Neuropsychology and cognitive function in Parkinson’s disease: an overview. In: Marsden CD, Fahn S, eds. Movement Disorders. 2nd ed. Stoneham, MA: Butterworths; 1987: 99–123.

    Google Scholar 

  20. Cedarbaum JM, McDowell FH. Sixteen-year follow-up of 100 patients begun on levodopa in 1968: emerging problems. Adv Neurol. 1986; 45: 469–472.

    Google Scholar 

  21. Critchley M. Arteriosclerotic parkinsonism. Brain. 1929; 52: 23–82.

    Article  Google Scholar 

  22. Meyer JS, Barron DW. Apraxia of gait: a clinico-physiological study. Brain. 1960; 83: 261–284.

    Article  Google Scholar 

  23. Estanol BV. Gait apraxia in communicating hydrocephalus. J Neurol Neurosurg Psychiatry. 1981; 44: 305–308.

    Article  PubMed  CAS  Google Scholar 

  24. Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger’s disease. Mov Disord. 1987; 2: 1–8.

    Article  PubMed  CAS  Google Scholar 

  25. Bannister R, Oppenheimer DR. Degenerative diseases of the nervous system associated with autonomic failure. Brain. 1972; 95: 457–474.

    Article  PubMed  CAS  Google Scholar 

  26. Steele JC. Progressive supranuclear palsy. Brain. 1972; 95: 693–705.

    PubMed  CAS  Google Scholar 

  27. Pearce J. The extrapyramidal disorder of Alzheimer’s disease. Eur Neurol. 1974; 12: 94–103.

    Article  PubMed  CAS  Google Scholar 

  28. Quinn NP, Marsden CD. The motor disorder of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1993; 56: 1239–1242.

    Article  PubMed  CAS  Google Scholar 

  29. Scully RE, Mark EJ, McNeely BU. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises—presentation of CASE 38–1985. N Engl J Med. 1985; 313: 739–748.

    Article  Google Scholar 

  30. Marsden CD, Parkes JD. Success and problems of long-term levodopa therapy in Parkinson’s disease. Lancet. 1977; 1: 345–349.

    Article  PubMed  CAS  Google Scholar 

  31. Fahn S, Calne DB. Considerations in the management of parkinsonism. Neurology. 1978; 28: 5–7.

    Article  PubMed  CAS  Google Scholar 

  32. Markham CH, Diamond SG. Long-term follow-up of early dopa treatment in Parkinson’s disease. Ann Neurol. 1986; 19: 365–372.

    Article  PubMed  CAS  Google Scholar 

  33. Cedarbaum JM, Gandy SE, McDowell FH. “Early” initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson’s disease. Neurology. 1991; 41: 622–629.

    Article  PubMed  CAS  Google Scholar 

  34. Weiner WJ, Factor SA, Sanchez-Ramos JR, et al. Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson’s disease. Neurology. 1993; 43: 21–27.

    Article  PubMed  CAS  Google Scholar 

  35. Swanson PD. Drug treatment of Parkinson’s disease: Is “polypharmacy” best ? J Neurol Neurosurg Psychiatry. 1994; 57: 401–403.

    Article  PubMed  CAS  Google Scholar 

  36. Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med. 1989; 321: 1364–1371.

    Google Scholar 

  37. The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med. 1993; 328: 176–183.

    Google Scholar 

  38. Marsden CD. Neurological management: Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1994; 57: 672–681.

    Article  PubMed  CAS  Google Scholar 

  39. Larsen TA, Calne DB. Essential tremor. Clin Neuro-pharmacol. 1983; 6: 185–206.

    CAS  Google Scholar 

  40. Koller WC, Huber SJ. Tremor disorders of aging: diagnosis and management. Geriatrics. 1989;44(5):33–36, 41.

    Google Scholar 

  41. Davis MB, Bateman D, Quinn NP, et al. Mutation analysis in patients with possible but apparently sporadic Huntington’s disease. Lancet. 1994; 344: 714–717.

    Article  PubMed  CAS  Google Scholar 

  42. Swanson PD, Luttrell CN, Magladery JW. Myoclonus: a report of 67 cases and a review of the literature. Medicine (Baltimore). 1962; 41: 339–356.

    Article  CAS  Google Scholar 

  43. Fahn S, Marsden CD, Van Woert MH. Definition and classification of myoclonus. Adv Neurol. 1986; 43: 1–5.

    PubMed  CAS  Google Scholar 

  44. Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol. 1983; 3: 402–411.

    Article  Google Scholar 

  45. Lane JM, Wienhold P, Kinon B, et al. Prevalence of abnormal involuntary movements (“spontaneous dyskinesias”) in the normal elderly. Psychopharmacology (Berlin). 1982; 77: 105–108.

    Article  Google Scholar 

  46. Aminoff JJ, Dedo HH, Izdebski K. Clinical aspects of spasmodic dysphonia. J Neurol Neurosurg Psychiatry. 1978; 41: 361–365.

    Article  PubMed  CAS  Google Scholar 

  47. Patterson RM, Little SC. Spasmodic torticollis. J Nerv Ment Dis. 1943; 98: 571–599.

    Article  Google Scholar 

  48. Sheehy MP, Marsden CD. Writers’ cramp: a focal dystonia. Brain. 1982; 105: 461–480.

    Article  PubMed  Google Scholar 

  49. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med. 1991; 324: 1186–1194.

    Article  PubMed  CAS  Google Scholar 

  50. Jankovic J. The neurology of tics. In: Marsden CD, Fahn S, eds. Movement Disorders. 2nd ed. Stoneham, MA: Butterworths; 1987: 383–405.

    Google Scholar 

  51. Ehni G, Wollman HW. Hemifacial spasm. Arch Neurol Psychiatry. 1945;53:205–211. J.G. Nutt

    Google Scholar 

  52. Janetta PJ, Abbasy M, Maroon JC, et al. Etiology and definitive microsurgical treatment of hemifacial spasm. J Neurosurg. 1977; 47: 321–328.

    Article  Google Scholar 

Download references

Authors
  1. John G. Nutt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Henry L. Schwartz Department of Geriatrics and Adult Development, The Mount Sinai Medical Center, 10029-6574, New York, NY, USA

    Christine K. Cassel M.D. (Professor and Chairman) & Diane E. Meier M.D. (Associate Professor) (Professor and Chairman) &  (Associate Professor)

  2. Center for Study of Aging and Geriatric Research Education and Clinical Center, Duke University Medical Center, 27710, Durham, NC, USA

    Harvey J. Cohen M.D. (Director) (Director)

  3. University of Washington Medical Center, 98195, Seattle, WA, USA

    Eric B. Larson M.D., M.P.H. (Medical Director) (Medical Director)

  4. Gerontology Division, Harvard Medical School, Brigham and Women’s Hospital, 02115, Boston, MA, USA

    Neil M. Resnick M.D. (Chief) (Chief)

  5. Geriatric Research Education and Clinical Center, Sepulveda VA Medical Center, 91343, Sepulveda, CA, USA

    Laurence Z. Rubenstein M.D., M.P.H. (Director) (Director)

  6. Department of Medicine, University of Chicago, 60637, Chicago, IL, USA

    Leif B. Sorensen M.D. (Professor and Vice Chairman) (Professor and Vice Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nutt, J.G. (1997). Abnormalities of Posture and Movement. In: Cassel, C.K., et al. Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2705-0_62

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2705-0_62

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-2707-4

  • Online ISBN: 978-1-4757-2705-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation